Andrew Radin

Andrew Radin is an experienced technology and pharmaceutical executive with a diverse background in mentorship, leadership, and advisory roles. Currently serving as Lead Mentor at StartX and Operating Advisor at Chorus, Andrew provides guidance on entrepreneurship and special projects. As CEO and Co-Founder of Aria Pharmaceuticals, Andrew led the development of innovative therapies for complex diseases. Previous roles include advisory positions at SPARK and Vanedge Capital, and key engineering leadership at Nivio, Locationary, and NeoEdge Networks. Andrew holds a Bachelor's and Master's degree in Computer Science from the Rochester Institute of Technology and studied computational biology at Stanford University.